Hemophilia B

6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Hemophilia B
Treatment and conditionWhere it standsTrials
CSL222 (AAV5-hFIXco-Padua) for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua) for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fidanacogene Elaparvovec for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Fitusiran for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Marstacimab for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SR604 for hemophilia bPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1